Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Myopic Vitreopathy clinical trials

1 of 1 indexed Myopic Vitreopathy trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Myopic Vitreopathy: 1 US clinical trial tracked, 1 recruiting.

Myopic Vitreopathy is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is VMR Consulting, running 1 of these trials.

Enrollment posture brief

Registry condition myopic-vitreopathy

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Myopic Vitreopathy (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Myopic Vitreopathy

Myopic Vitreopathy lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Myopic Vitreopathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Myopic Vitreopathy is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

VMR Consulting 1 trials

Named interventions

Most-linked intervention names on Myopic Vitreopathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser therapy Device
1 trials

US sites by state

Facility locations filed on Myopic Vitreopathy trials. A trial with sites in several states counts in each.

California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Myopic Vitreopathy page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Myopic Vitreopathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • VMR Consulting sponsors the most Myopic Vitreopathy trials on record, review their full trial history before evaluating a specific study. See VMR Consulting's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myopic Vitreopathy condition card totals 1 registered trials; most-linked intervention Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser therapy; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.